cdn mobile

PH to sign COVID-19 vaccine deal with AstraZeneca on Friday

By: Darryl John Esguerra - Reporter / @DJEsguerraINQ - Inquirer.net | November 26,2020 - 01:59 PM

MANILA, Philippines — The Philippine government, together with local private companies, will sign a tripartite agreement with British drugmaker AstraZeneca on Friday for the purchase of its COVID-19 vaccine.

The country’s vaccine czar Secretary Carlito Galvez Jr. said during a televised Palace press briefing Thursday that 2 million doses of AstraZeneca’s vaccine will be purchased under the deal.

“This coming Friday pipirma po tayo ng tripartite agreement na kung saan tayo po ay makakabili ng dalawang milyong doses ng bakuna mula sa AstraZeneca ng United Kingdom. Kasama po natin ang pribadong sektor na nagdonate nito,” Galvez said.

Astra Zeneca earlier said its COVID-19 vaccine was 70% effective in pivotal trials and could be up to 90% effective, and can be cheaper to make, easier to distribute and faster to scale-up than rivals.

EDV

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: AstraZeneca, COVID-19, Galvez, vaccine czar
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.